Tipifarnib in Preventing Cancer in Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas - Related Studies

Tipifarnib in Preventing Cancer in Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas

This study is currently recruiting participants.

Study NCT00029354. Last updated on October 18, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Neurofibromatosis Type 1 (nf1)
		Precancerous/Nonmalignant Condition
		Sarcoma

2	Additional conditions recognized in this trial
		Neurofibroma
		Neurofibroma, Plexiform
		Neurofibromatoses
		Neurofibromatosis 1
		Precancerous Conditions

3	More general conditions related to this trial
		Genetic Diseases, Inborn
		Heredodegenerative Disorders, Nervous System
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms, Connective and Soft Tissue
		Neoplasms, Nerve Tissue
		Neoplastic Syndromes, Hereditary
		Nerve Sheath Neoplasms
		Nervous System Diseases
		Nervous System Neoplasms
		Neurocutaneous Syndromes
		Neurodegenerative Diseases
		Neuromuscular Diseases
		Peripheral Nervous System Diseases
		Peripheral Nervous System Neoplasms

4	Interventions listed in this trial
		placebo
		tipifarnib

5	More general drug interventions related to this trial
		Antineoplastic Agents
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		NCI - Center for Cancer Research-Medical Oncology
		National Cancer Institute (NCI)